Equifax Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $36.8 Billion | 2/12 | VRSK $38.4B |
EFX $36.8B |
BAH $20.0B |
TRU $19.1B |
FCN $7.9B |
EXPO $5.3B |
ICFI $3.1B |
HURN $1.9B |
CRAI $1.1B |
FC $504.1M |
FORR $353.9M |
RGP $330.0M |
Gross Margin | 44% | 5/12 | FC 74% |
VRSK 59% |
FORR 54% |
TRU 48% |
EFX 44% |
RGP 39% |
ICFI 33% |
FCN 33% |
HURN 31% |
EXPO 30% |
CRAI 25% |
BAH 20% |
Profit Margin | 11% | 3/12 | VRSK 43% |
EXPO 21% |
EFX 11% |
HURN 10% |
FCN 9% |
TRU 8% |
FC 8% |
RGP 7% |
BAH 6% |
ICFI 5% |
FORR 5% |
CRAI 4% |
EBITDA margin | 31% | 2/12 | VRSK 55% |
EFX 31% |
TRU 31% |
EXPO 27% |
FC 15% |
HURN 14% |
FORR 13% |
FCN 12% |
ICFI 11% |
BAH 10% |
CRAI 10% |
RGP 9% |
Quarterly Revenue | $1.4 Billion | 2/12 | BAH $2.9B |
EFX $1.4B |
TRU $1.0B |
FCN $949.2M |
VRSK $716.8M |
ICFI $512.0M |
HURN $381.0M |
CRAI $171.4M |
RGP $148.2M |
EXPO $140.5M |
FORR $121.8M |
FC $73.4M |
Quarterly Earnings | $163.9 Million | 3/12 | VRSK $308.1M |
BAH $164.4M |
EFX $163.9M |
TRU $85.0M |
FCN $83.9M |
HURN $37.5M |
EXPO $29.2M |
ICFI $25.6M |
RGP $10.5M |
CRAI $6.5M |
FORR $6.3M |
FC $5.7M |
Quarterly Free Cash Flow | $130.8 Million | 3/12 | TRU $218.1M |
VRSK $162.4M |
EFX $130.8M |
FCN $125.2M |
HURN $98.2M |
ICFI $55.5M |
EXPO $47.2M |
BAH $19.7M |
FC $5.8M |
RGP $3.2M |
FORR -$0 |
CRAI -$509,000 |
Trailing 4 Quarters Revenue | $5.5 Billion | 2/12 | BAH $10.9B |
EFX $5.5B |
TRU $4.0B |
FCN $3.7B |
VRSK $2.8B |
ICFI $2.0B |
HURN $1.5B |
EXPO $655.6M |
CRAI $652.4M |
RGP $632.8M |
FORR $453.4M |
FC $281.1M |
Trailing 4 Quarters Earnings | $583.4 Million | 3/12 | BAH $2.9B |
EFX $1.4B |
TRU $1.0B |
FCN $949.2M |
VRSK $716.8M |
ICFI $512.0M |
HURN $381.0M |
CRAI $171.4M |
RGP $148.2M |
EXPO $140.5M |
FORR $121.8M |
FC $73.4M |
Quarterly Earnings Growth | 19% | 6/12 | VRSK 56% |
HURN 52% |
FCN 35% |
ICFI 26% |
FC 25% |
EFX 19% |
FORR 19% |
EXPO 14% |
BAH 2% |
TRU -11% |
RGP -11% |
CRAI -31% |
Annual Earnings Growth | 23% | 6/12 | BAH 1492% |
FORR 121% |
FC 87% |
FCN 60% |
ICFI 42% |
EFX 23% |
HURN 23% |
VRSK 14% |
CRAI 11% |
EXPO -7% |
RGP -36% |
TRU -207% |
Quarterly Revenue Growth | 9% | 3/12 | BAH 11% |
FCN 10% |
EFX 9% |
TRU 8% |
HURN 7% |
VRSK 6% |
CRAI 6% |
FC 3% |
ICFI 2% |
EXPO 0% |
FORR -10% |
RGP -20% |
Annual Revenue Growth | 5% | 7/12 | EXPO 17% |
FCN 13% |
BAH 10% |
HURN 10% |
FC 9% |
VRSK 6% |
EFX 5% |
TRU 5% |
CRAI 5% |
ICFI 2% |
FORR -5% |
RGP -15% |
Cash On Hand | $181.9 Million | 6/12 | VRSK $635.9M |
TRU $543.2M |
BAH $297.7M |
FCN $226.4M |
EXPO $203.3M |
EFX $181.9M |
RGP $108.9M |
FORR $58.9M |
FC $36.6M |
CRAI $24.6M |
HURN $17.6M |
ICFI $4.8M |
Short Term Debt | $769.6 Million | 1/12 | EFX $769.6M |
VRSK $543.7M |
BAH $119.5M |
CRAI $104.0M |
TRU $89.9M |
FCN $37.5M |
ICFI $36.1M |
HURN $25.3M |
FORR $13.6M |
FC $5.9M |
EXPO $4.9M |
RGP $4.7M |
Long Term Debt | $4.7 Billion | 2/12 | TRU $5.2B |
EFX $4.7B |
BAH $3.3B |
VRSK $2.5B |
HURN $496.6M |
ICFI $421.6M |
CRAI $84.5M |
EXPO $70.4M |
FCN $60.0M |
FORR $35.0M |
RGP $8.6M |
FC $761,000 |
PE | 63.16 | 2/12 | FORR 245.79 |
EFX 63.16 |
EXPO 50.91 |
VRSK 43.16 |
BAH 32.90 |
ICFI 31.38 |
FC 27.61 |
CRAI 27.24 |
FCN 24.04 |
HURN 23.57 |
RGP 15.69 |
TRU -1.00 |
PS | 6.74 | 3/12 | VRSK 13.82 |
EXPO 8.14 |
EFX 6.74 |
TRU 4.79 |
FCN 2.14 |
BAH 1.83 |
FC 1.79 |
CRAI 1.68 |
ICFI 1.56 |
HURN 1.29 |
FORR 0.78 |
RGP 0.52 |
PB | 7.62 | 4/12 | VRSK 88.13 |
BAH 18.44 |
EXPO 13.57 |
EFX 7.62 |
FC 6.99 |
CRAI 5.72 |
TRU 4.50 |
HURN 3.76 |
FCN 3.68 |
ICFI 3.29 |
FORR 1.49 |
RGP 0.79 |
PC | 202.56 | 2/12 | ICFI 650.48 |
EFX 202.56 |
HURN 106.62 |
BAH 67.16 |
VRSK 60.33 |
CRAI 44.49 |
TRU 35.11 |
FCN 34.92 |
EXPO 26.26 |
FC 13.78 |
FORR 6.01 |
RGP 3.03 |
Liabilities to Equity | 1.56 | 7/12 | VRSK 10.07 |
BAH 5.13 |
FC 2.06 |
CRAI 1.85 |
HURN 1.65 |
TRU 1.64 |
EFX 1.56 |
FORR 1.21 |
ICFI 1.13 |
EXPO 0.80 |
FCN 0.56 |
RGP 0.22 |
ROA | 0.05 | 8/12 | VRSK 19% | EXPO 15% | FCN 10% | BAH 9% | FC 8% | CRAI 7% | HURN 6% | EFX 5% | ICFI 5% | RGP 4% | FORR 0% | TRU -2% |
ROE | 0.12 | 8/12 | VRSK 207% |
BAH 56% |
EXPO 27% |
FC 25% |
CRAI 21% |
HURN 16% |
FCN 15% |
EFX 12% |
ICFI 10% |
RGP 5% |
FORR 1% |
TRU -7% |
Current Ratio | 1.66 | 6/12 | RGP 5.54 |
FCN 2.78 |
EXPO 2.24 |
ICFI 1.89 |
FORR 1.83 |
EFX 1.66 |
TRU 1.62 |
HURN 1.61 |
CRAI 1.54 |
FC 1.48 |
BAH 1.20 |
VRSK 1.10 |
Quick Ratio | 0.02 | 10/12 | FORR 245.79 |
EFX 63.16 |
EXPO 50.91 |
VRSK 43.16 |
BAH 32.90 |
ICFI 31.38 |
FC 27.61 |
CRAI 27.24 |
FCN 24.04 |
HURN 23.57 |
RGP 15.69 |
TRU -1.00 |
Long Term Debt to Equity | 1.01 | 4/12 | VRSK} 5.85 |
BAH} 3.07 |
TRU} 1.25 |
EFX} 1.01 |
HURN} 0.99 |
ICFI} 0.45 |
CRAI} 0.44 |
EXPO} 0.18 |
FORR} 0.15 |
FCN} 0.03 |
RGP} 0.02 |
FC} 0.01 |
Debt to Equity | 1.17 | 4/12 | VRSK 7.64 |
BAH 3.35 |
TRU 1.29 |
EFX 1.17 |
HURN 1.11 |
CRAI 0.98 |
ICFI 0.67 |
FORR 0.34 |
EXPO 0.19 |
FCN 0.15 |
FC 0.11 |
RGP 0.03 |
Burn Rate | 0.83 | 4/12 | ICFI 16.97 |
TRU 3.76 |
CRAI 1.08 |
EFX 0.83 |
HURN -1.56 |
FCN -3.14 |
EXPO -8.07 |
FC -8.67 |
VRSK -8.90 |
RGP -12.17 |
FORR -39.38 |
BAH -222.64 |
Cash to Cap | 0.00 | 11/12 | RGP 0.33 |
FORR 0.17 |
FC 0.07 |
EXPO 0.04 |
TRU 0.03 |
FCN 0.03 |
VRSK 0.02 |
CRAI 0.02 |
BAH 0.01 |
HURN 0.01 |
EFX 0.00 |
ICFI 0.00 |
CCR | 0.80 | 7/12 | HURN 2.62 |
TRU 2.57 |
ICFI 2.17 |
EXPO 1.61 |
FCN 1.49 |
FC 1.02 |
EFX 0.80 |
VRSK 0.53 |
RGP 0.30 |
BAH 0.12 |
FORR 0.00 |
CRAI -0.08 |
EV to EBITDA | 94.35 | 3/12 | EXPO} 136.26 |
VRSK} 103.61 |
EFX} 94.35 |
BAH} 77.24 |
TRU} 73.69 |
CRAI} 70.04 |
FCN} 68.94 |
ICFI} 66.69 |
HURN} 46.85 |
FC} 42.88 |
FORR} 23.48 |
RGP} 17.47 |
EV to Revenue | 7.72 | 3/12 | VRSK 14.78 |
EXPO 7.95 |
EFX 7.72 |
TRU 5.99 |
FCN 2.16 |
BAH 2.13 |
CRAI 1.93 |
ICFI 1.88 |
FC 1.69 |
HURN 1.66 |
FORR 0.83 |
RGP 0.37 |